Discover trends, market shifts, and competitive outlooks for the immunohistochemistry (ihc) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Immunohistochemistry (IHC) Market Through 2034?

The industry of immunohistochemistry (IHC) has seen significant growth in previous years. It is projected to increase from $2.58 billion in 2024 to $2.78 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.0%. The past growth can be credited to the acceptance in clinical fields, standardization throughout the industry, the rise in cancer study, lab automation, and advancements in clinical diagnostics.

The market size for immunohistochemistry (IHC) is projected to experience a swift expansion in the coming years, reaching $4.13 billion in 2029, with a compound annual growth rate (CAGR) of 10.4%. This surge in the forecast period is due to the advent of new market participants, an increase in demand in drug development, integration of biomedical research, technological applications for diagnosis, as well as automation and digitalization. Upcoming trends for the forecast period include developments in multiplex IHC methodologies, integration of digital pathology, improvements in antibody specificity, automation, standardization and usage in biomarker detection.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Immunohistochemistry (IHC) Market?

The rise in the occurrence of chronic diseases, defined as medical conditions lasting three months or more and typically manageable but incurable, is predicted to spur the growth of the immunohistochemistry (IHC) market. This is because of the role IHC plays in diagnosing chronic ailments such as cancer, cardiovascular diseases, among others, owing to its attributes like specificity, sensitivity (used to identify specific antigens), and quick outcomes. For example, the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that approximately 37.3 million people, equating to 11.3% of the US population, had diabetes in 2022. As such, the escalating occurrence of chronic diseases is a key driver in expanding the immunohistochemistry (IHC) market.

Which Key Market Segments Comprise the Immunohistochemistry (IHC) Market and Drive Its Revenue Growth?

The immunohistochemistry (IHC) market covered in this report is segmented –

1) By Product: Antibodies, Equipment, Reagents, Kits

2) By Applications: Diagnostics, Drug Testing, Other Applications

3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies

2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes

3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media

4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9267&type=smp

Which Areas Are Leading Regions in the Immunohistochemistry (IHC) Market Expansion Across the Globe?

North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering theImmunohistochemistry (IHC) Market Direction?

Leading organizations within the immunohistochemistry (IHC) sector are emphasizing the advancement of diagnostic precision via cutting-edge technologies and superior reagents to increase tissue analysis efficiency in various clinical and research applications. The Neoflex multiomics mass spectrometry imaging (MSI) system is an innovative imaging platform constructed for accurate tissue analysis. It allows researchers to seamlessly transition from the phase of discovery to clinical applications via detailed mass spectrometry techniques, particularly in the spatial mapping of biomolecules within tissues. For example, in June 2024, Bruker Corporation, an American firm that creates and manufactures scientific tools as well as diagnostic and analytic solutions, unveiled their matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for tissue imaging based on mass spectrometry. The Neoflex multiomics mass spectrometry imaging (MSI) system caters to the need to progress from discovery imaging to clinical tissue investigation. The system incorporates Bruker’s 10-kHz smartbeam 3D laser and improved imaging detectors, along with supporting OME-TIFF file output facilitated via SCiLS Scope software.

View the full report here:

https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

How Is the Immunohistochemistry (IHC) Market Conceptually Defined?

Immunohistochemistry (IHC) is the technique in diagnosis that uses antibody-antigen interaction to locate particular proteins and antigens in the tissue section. This interaction is visualized using chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dye.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9267

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model